Author Correction: [11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease (Nature Communications, (2022), 13, 1, (4171), 10.1038/s41467-022-30653-5)

Tharick A. Pascoal; Mira Chamoun; Elad Lax; Hsiao Ying Wey; Monica Shin; Kok Pin Ng; Min Su Kang; Sulantha Mathotaarachchi; Andrea L. Benedet; Joseph Therriault; Firoza Z. Lussier; Frederick A. Schroeder; Jonathan M. DuBois; Baileigh G. Hightower; Tonya M. Gilbert; Nicole R. Zürcher; Changning Wang; Robert Hopewell; Mallar Chakravarty; Melissa Savard; Emilie Thomas; Sara Mohaddes; Sarah Farzin; Alyssa Salaciak; Stephanie Tullo; A. Claudio Cuello; Jean Paul Soucy; Gassan Massarweh; Heungsun Hwang; Eliane Kobayashi; Bradley T. Hyman; Bradford C. Dickerson; Marie Christine Guiot; Moshe Szyf; Serge Gauthier; Jacob M. Hooker; Pedro Rosa-Neto

doi:10.1038/s41467-022-33668-0

Author Correction: [¹¹C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease (Nature Communications, (2022), 13, 1, (4171), 10.1038/s41467-022-30653-5)

Tharick A. Pascoal, Mira Chamoun, Elad Lax, Hsiao Ying Wey, Monica Shin, Kok Pin Ng, Min Su Kang, Sulantha Mathotaarachchi, Andrea L. Benedet, Joseph Therriault, Firoza Z. Lussier, Frederick A. Schroeder, Jonathan M. DuBois, Baileigh G. Hightower, Tonya M. Gilbert, Nicole R. Zürcher, Changning Wang, Robert Hopewell, Mallar Chakravarty, Melissa SavardEmilie Thomas, Sara Mohaddes, Sarah Farzin, Alyssa Salaciak, Stephanie Tullo, A. Claudio Cuello, Jean Paul Soucy, Gassan Massarweh, Heungsun Hwang, Eliane Kobayashi, Bradley T. Hyman, Bradford C. Dickerson, Marie Christine Guiot, Moshe Szyf, Serge Gauthier, Jacob M. Hooker, Pedro Rosa-Neto

Department of Molecular Biology

Research output: Contribution to journal › Comment/debate

Abstract

In this article the funding from ‘Alzheimer’s Drug Discovery Foundation (ADDF)’ was omitted. The original article has been corrected.

Original language	English
Article number	5833
Journal	Nature Communications
Volume	13
Issue number	1
DOIs	https://doi.org/10.1038/s41467-022-33668-0
State	Published - Dec 2022

Access to Document

10.1038/s41467-022-33668-0

Cite this

Pascoal, T. A., Chamoun, M., Lax, E., Wey, H. Y., Shin, M., Ng, K. P., Kang, M. S., Mathotaarachchi, S., Benedet, A. L., Therriault, J., Lussier, F. Z., Schroeder, F. A., DuBois, J. M., Hightower, B. G., Gilbert, T. M., Zürcher, N. R., Wang, C., Hopewell, R., Chakravarty, M., ... Rosa-Neto, P. (2022). Author Correction: [¹¹C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease (Nature Communications, (2022), 13, 1, (4171), 10.1038/s41467-022-30653-5). Nature Communications, 13(1), Article 5833. https://doi.org/10.1038/s41467-022-33668-0

@article{e1829a6096ba402fbce6933b9a9fdc2e,

title = "Author Correction: [11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer{\textquoteright}s disease (Nature Communications, (2022), 13, 1, (4171), 10.1038/s41467-022-30653-5)",

abstract = "In this article the funding from {\textquoteleft}Alzheimer{\textquoteright}s Drug Discovery Foundation (ADDF){\textquoteright} was omitted. The original article has been corrected.",

author = "Pascoal, {Tharick A.} and Mira Chamoun and Elad Lax and Wey, {Hsiao Ying} and Monica Shin and Ng, {Kok Pin} and Kang, {Min Su} and Sulantha Mathotaarachchi and Benedet, {Andrea L.} and Joseph Therriault and Lussier, {Firoza Z.} and Schroeder, {Frederick A.} and DuBois, {Jonathan M.} and Hightower, {Baileigh G.} and Gilbert, {Tonya M.} and Z{\"u}rcher, {Nicole R.} and Changning Wang and Robert Hopewell and Mallar Chakravarty and Melissa Savard and Emilie Thomas and Sara Mohaddes and Sarah Farzin and Alyssa Salaciak and Stephanie Tullo and Cuello, {A. Claudio} and Soucy, {Jean Paul} and Gassan Massarweh and Heungsun Hwang and Eliane Kobayashi and Hyman, {Bradley T.} and Dickerson, {Bradford C.} and Guiot, {Marie Christine} and Moshe Szyf and Serge Gauthier and Hooker, {Jacob M.} and Pedro Rosa-Neto",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2022.",

year = "2022",

month = dec,

doi = "10.1038/s41467-022-33668-0",

language = "אנגלית",

volume = "13",

journal = "Nature Communications",

issn = "2041-1723",

publisher = "Nature Publishing Group",

number = "1",

}

Pascoal, TA, Chamoun, M, Lax, E, Wey, HY, Shin, M, Ng, KP, Kang, MS, Mathotaarachchi, S, Benedet, AL, Therriault, J, Lussier, FZ, Schroeder, FA, DuBois, JM, Hightower, BG, Gilbert, TM, Zürcher, NR, Wang, C, Hopewell, R, Chakravarty, M, Savard, M, Thomas, E, Mohaddes, S, Farzin, S, Salaciak, A, Tullo, S, Cuello, AC, Soucy, JP, Massarweh, G, Hwang, H, Kobayashi, E, Hyman, BT, Dickerson, BC, Guiot, MC, Szyf, M, Gauthier, S, Hooker, JM & Rosa-Neto, P 2022, 'Author Correction: [¹¹C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease (Nature Communications, (2022), 13, 1, (4171), 10.1038/s41467-022-30653-5)', Nature Communications, vol. 13, no. 1, 5833. https://doi.org/10.1038/s41467-022-33668-0

TY - JOUR

T1 - Author Correction

T2 - [11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease (Nature Communications, (2022), 13, 1, (4171), 10.1038/s41467-022-30653-5)

AU - Pascoal, Tharick A.

AU - Chamoun, Mira

AU - Lax, Elad

AU - Wey, Hsiao Ying

AU - Shin, Monica

AU - Ng, Kok Pin

AU - Kang, Min Su

AU - Mathotaarachchi, Sulantha

AU - Benedet, Andrea L.

AU - Therriault, Joseph

AU - Lussier, Firoza Z.

AU - Schroeder, Frederick A.

AU - DuBois, Jonathan M.

AU - Hightower, Baileigh G.

AU - Gilbert, Tonya M.

AU - Zürcher, Nicole R.

AU - Wang, Changning

AU - Hopewell, Robert

AU - Chakravarty, Mallar

AU - Savard, Melissa

AU - Thomas, Emilie

AU - Mohaddes, Sara

AU - Farzin, Sarah

AU - Salaciak, Alyssa

AU - Tullo, Stephanie

AU - Cuello, A. Claudio

AU - Soucy, Jean Paul

AU - Massarweh, Gassan

AU - Hwang, Heungsun

AU - Kobayashi, Eliane

AU - Hyman, Bradley T.

AU - Dickerson, Bradford C.

AU - Guiot, Marie Christine

AU - Szyf, Moshe

AU - Gauthier, Serge

AU - Hooker, Jacob M.

AU - Rosa-Neto, Pedro

PY - 2022/12

Y1 - 2022/12

N2 - In this article the funding from ‘Alzheimer’s Drug Discovery Foundation (ADDF)’ was omitted. The original article has been corrected.

AB - In this article the funding from ‘Alzheimer’s Drug Discovery Foundation (ADDF)’ was omitted. The original article has been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85139169640&partnerID=8YFLogxK

U2 - 10.1038/s41467-022-33668-0

DO - 10.1038/s41467-022-33668-0

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 36192402

AN - SCOPUS:85139169640

SN - 2041-1723

VL - 13

JO - Nature Communications

JF - Nature Communications

IS - 1

M1 - 5833

ER -

Author Correction: [¹¹C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease (Nature Communications, (2022), 13, 1, (4171), 10.1038/s41467-022-30653-5)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this